The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
ABSTRACT Purpose We evaluated the 7th edition of the American Joint Committee on Cancer (AJCC) staging classification in terms of overall survival (OS) in patients with PMP treated with cytoreductive surgery (CRS)/hyperthermic intraperitoneal chemotherapy (HIPEC). Methods A total of 208 PMP patients...
Gespeichert in:
| Veröffentlicht in: | Annals of surgical oncology 2016-06, Vol.23 (6), p.1928-1933 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1933 |
|---|---|
| container_issue | 6 |
| container_start_page | 1928 |
| container_title | Annals of surgical oncology |
| container_volume | 23 |
| creator | Milovanov, Vladimir Sardi, Armando Studeman, Kimberley Nieroda, Carol Sittig, Michelle Gushchin, Vadim |
| description | ABSTRACT
Purpose
We evaluated the 7th edition of the American Joint Committee on Cancer (AJCC) staging classification in terms of overall survival (OS) in patients with PMP treated with cytoreductive surgery (CRS)/hyperthermic intraperitoneal chemotherapy (HIPEC).
Methods
A total of 208 PMP patients treated with CRS/HIPEC were identified from a prospective database. Patients with peritoneal mucinous carcinomatosis (PMCA) were retrospectively staged at time of diagnosis according to AJCC staging classification. Patients with disseminated peritoneal adenomucinosis (DPAM) were evaluated in a separate group.
Results
Median follow-up was 5.2 years. Of 208 patients, 124 had PMCA and 84 patients had DPAM. According to the AJCC staging classification 47 lymph node (LN) negative patients with well-differentiated PMCA, were classified as a stage IVA. 77 patients with either moderately or poorly differentiated PMCA irrespective of LN status, or well-differentiated PMCA with positive LN were classified as stage IVB. 84 patients with DPAM, constituted a separate group. OS of stage IVA and IVB patients was 100, 90, 67, and 91, 50, and 27 for 1, 3, and 5 years, respectively (
p
|
| doi_str_mv | 10.1245/s10434-015-5047-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1787479054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1787479054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-b97c6d8b120b13ca966bf82a24e28d2b47bc50459073f4a40acc440a092abb683</originalsourceid><addsrcrecordid>eNp1ks9u1DAQxiMEoqXwAFyQJS7lEGo7dpwct9HCLmpFxS7nyHEmu66SONhOUV6Zp8DZlD9CQrJsa-b7fmONJ4peE_yeUMavHMEsYTEmPOaYiZg_ic4JDxGWZuRpuOM0i3Oa8rPohXP3GBORYP48OqOpICzn5Dz6sT8CEv6I1rX22vTINMiH0OpTUaCdlwfdH1DRSud0o5U8SQpjLbTSg0PfdbBea9Oag1boGo7yQRs7Q25HpXszOrQaBuhrrUC2aD92IXsy3YHV3vRz9Ba8dGEF3t5C4NaLpJi8sVCPyusHQLvRHsBOSPY12kwD2PBM24Wq295bOfzBFUfozJyUw4Quiy-7q832bl28exk9a2Tr4NXjeRF9_bDeF5v45vPHbbG6iVUiqI-rXKi0zipCcUUSJfM0rZqMSsqAZjWtmKhU6DbPsUgaJhmWSrGw45zKqkqz5CK6XLiDNd9GcL7stFPQtrKH0JCSiEwwkWPOgvTtP9J7M9o-vO6kwglPshlIFpWyxjkLTTlY3Uk7lQSX8yCUyyCUYRDKeRBKHjxvHslj1UH92_Hr54OALgIXUn3o7F-l_0v9CaPJwcM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1787035388</pqid></control><display><type>article</type><title>The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Milovanov, Vladimir ; Sardi, Armando ; Studeman, Kimberley ; Nieroda, Carol ; Sittig, Michelle ; Gushchin, Vadim</creator><creatorcontrib>Milovanov, Vladimir ; Sardi, Armando ; Studeman, Kimberley ; Nieroda, Carol ; Sittig, Michelle ; Gushchin, Vadim</creatorcontrib><description>ABSTRACT
Purpose
We evaluated the 7th edition of the American Joint Committee on Cancer (AJCC) staging classification in terms of overall survival (OS) in patients with PMP treated with cytoreductive surgery (CRS)/hyperthermic intraperitoneal chemotherapy (HIPEC).
Methods
A total of 208 PMP patients treated with CRS/HIPEC were identified from a prospective database. Patients with peritoneal mucinous carcinomatosis (PMCA) were retrospectively staged at time of diagnosis according to AJCC staging classification. Patients with disseminated peritoneal adenomucinosis (DPAM) were evaluated in a separate group.
Results
Median follow-up was 5.2 years. Of 208 patients, 124 had PMCA and 84 patients had DPAM. According to the AJCC staging classification 47 lymph node (LN) negative patients with well-differentiated PMCA, were classified as a stage IVA. 77 patients with either moderately or poorly differentiated PMCA irrespective of LN status, or well-differentiated PMCA with positive LN were classified as stage IVB. 84 patients with DPAM, constituted a separate group. OS of stage IVA and IVB patients was 100, 90, 67, and 91, 50, and 27 for 1, 3, and 5 years, respectively (
p
< 0.001). OS of DPAM patients was 96, 90, and 88 % for 1, 3, and 5 years, respectively (
p
= 0.025 comparing to IVA). PFS was estimated for IVA and IVB PMCA patients who were considered disease free after CRS/HIPEC and was 78, 52, and 43 % in the IVA patients and 65 %, 15 %, and 0 in the IVB group at 1, 3, and 5 years, respectively (
p
= 0.004). The adjusted HR for AJCC stages (IVA/IVB) was 3.7 (95 % confidence interval 2.0–6.7) (
p
< 0.001).
Conclusions
The 7th edition of the AJCC staging classification is a simple, reproducible, and valid classification for staging patients with PMCA undergoing CRS/HIPEC.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-015-5047-5</identifier><identifier>PMID: 26714951</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Adenocarcinoma, Mucinous - classification ; Adenocarcinoma, Mucinous - pathology ; Adenocarcinoma, Mucinous - therapy ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Appendiceal Neoplasms - classification ; Appendiceal Neoplasms - pathology ; Appendiceal Neoplasms - therapy ; Chemotherapy, Cancer, Regional Perfusion ; Combined Modality Therapy ; Cytoreduction Surgical Procedures ; Female ; Follow-Up Studies ; Gastrointestinal Oncology ; Humans ; Hyperthermia, Induced ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Oncology ; Peritoneal Neoplasms - classification ; Peritoneal Neoplasms - secondary ; Peritoneal Neoplasms - therapy ; Prognosis ; Prospective Studies ; Retrospective Studies ; Surgery ; Surgical Oncology ; Survival Rate</subject><ispartof>Annals of surgical oncology, 2016-06, Vol.23 (6), p.1928-1933</ispartof><rights>Society of Surgical Oncology 2015</rights><rights>Society of Surgical Oncology 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-b97c6d8b120b13ca966bf82a24e28d2b47bc50459073f4a40acc440a092abb683</citedby><cites>FETCH-LOGICAL-c372t-b97c6d8b120b13ca966bf82a24e28d2b47bc50459073f4a40acc440a092abb683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-015-5047-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-015-5047-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26714951$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Milovanov, Vladimir</creatorcontrib><creatorcontrib>Sardi, Armando</creatorcontrib><creatorcontrib>Studeman, Kimberley</creatorcontrib><creatorcontrib>Nieroda, Carol</creatorcontrib><creatorcontrib>Sittig, Michelle</creatorcontrib><creatorcontrib>Gushchin, Vadim</creatorcontrib><title>The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><description>ABSTRACT
Purpose
We evaluated the 7th edition of the American Joint Committee on Cancer (AJCC) staging classification in terms of overall survival (OS) in patients with PMP treated with cytoreductive surgery (CRS)/hyperthermic intraperitoneal chemotherapy (HIPEC).
Methods
A total of 208 PMP patients treated with CRS/HIPEC were identified from a prospective database. Patients with peritoneal mucinous carcinomatosis (PMCA) were retrospectively staged at time of diagnosis according to AJCC staging classification. Patients with disseminated peritoneal adenomucinosis (DPAM) were evaluated in a separate group.
Results
Median follow-up was 5.2 years. Of 208 patients, 124 had PMCA and 84 patients had DPAM. According to the AJCC staging classification 47 lymph node (LN) negative patients with well-differentiated PMCA, were classified as a stage IVA. 77 patients with either moderately or poorly differentiated PMCA irrespective of LN status, or well-differentiated PMCA with positive LN were classified as stage IVB. 84 patients with DPAM, constituted a separate group. OS of stage IVA and IVB patients was 100, 90, 67, and 91, 50, and 27 for 1, 3, and 5 years, respectively (
p
< 0.001). OS of DPAM patients was 96, 90, and 88 % for 1, 3, and 5 years, respectively (
p
= 0.025 comparing to IVA). PFS was estimated for IVA and IVB PMCA patients who were considered disease free after CRS/HIPEC and was 78, 52, and 43 % in the IVA patients and 65 %, 15 %, and 0 in the IVB group at 1, 3, and 5 years, respectively (
p
= 0.004). The adjusted HR for AJCC stages (IVA/IVB) was 3.7 (95 % confidence interval 2.0–6.7) (
p
< 0.001).
Conclusions
The 7th edition of the AJCC staging classification is a simple, reproducible, and valid classification for staging patients with PMCA undergoing CRS/HIPEC.</description><subject>Adenocarcinoma, Mucinous - classification</subject><subject>Adenocarcinoma, Mucinous - pathology</subject><subject>Adenocarcinoma, Mucinous - therapy</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Appendiceal Neoplasms - classification</subject><subject>Appendiceal Neoplasms - pathology</subject><subject>Appendiceal Neoplasms - therapy</subject><subject>Chemotherapy, Cancer, Regional Perfusion</subject><subject>Combined Modality Therapy</subject><subject>Cytoreduction Surgical Procedures</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastrointestinal Oncology</subject><subject>Humans</subject><subject>Hyperthermia, Induced</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Oncology</subject><subject>Peritoneal Neoplasms - classification</subject><subject>Peritoneal Neoplasms - secondary</subject><subject>Peritoneal Neoplasms - therapy</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1ks9u1DAQxiMEoqXwAFyQJS7lEGo7dpwct9HCLmpFxS7nyHEmu66SONhOUV6Zp8DZlD9CQrJsa-b7fmONJ4peE_yeUMavHMEsYTEmPOaYiZg_ic4JDxGWZuRpuOM0i3Oa8rPohXP3GBORYP48OqOpICzn5Dz6sT8CEv6I1rX22vTINMiH0OpTUaCdlwfdH1DRSud0o5U8SQpjLbTSg0PfdbBea9Oag1boGo7yQRs7Q25HpXszOrQaBuhrrUC2aD92IXsy3YHV3vRz9Ba8dGEF3t5C4NaLpJi8sVCPyusHQLvRHsBOSPY12kwD2PBM24Wq295bOfzBFUfozJyUw4Quiy-7q832bl28exk9a2Tr4NXjeRF9_bDeF5v45vPHbbG6iVUiqI-rXKi0zipCcUUSJfM0rZqMSsqAZjWtmKhU6DbPsUgaJhmWSrGw45zKqkqz5CK6XLiDNd9GcL7stFPQtrKH0JCSiEwwkWPOgvTtP9J7M9o-vO6kwglPshlIFpWyxjkLTTlY3Uk7lQSX8yCUyyCUYRDKeRBKHjxvHslj1UH92_Hr54OALgIXUn3o7F-l_0v9CaPJwcM</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Milovanov, Vladimir</creator><creator>Sardi, Armando</creator><creator>Studeman, Kimberley</creator><creator>Nieroda, Carol</creator><creator>Sittig, Michelle</creator><creator>Gushchin, Vadim</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160601</creationdate><title>The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)</title><author>Milovanov, Vladimir ; Sardi, Armando ; Studeman, Kimberley ; Nieroda, Carol ; Sittig, Michelle ; Gushchin, Vadim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-b97c6d8b120b13ca966bf82a24e28d2b47bc50459073f4a40acc440a092abb683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenocarcinoma, Mucinous - classification</topic><topic>Adenocarcinoma, Mucinous - pathology</topic><topic>Adenocarcinoma, Mucinous - therapy</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Appendiceal Neoplasms - classification</topic><topic>Appendiceal Neoplasms - pathology</topic><topic>Appendiceal Neoplasms - therapy</topic><topic>Chemotherapy, Cancer, Regional Perfusion</topic><topic>Combined Modality Therapy</topic><topic>Cytoreduction Surgical Procedures</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastrointestinal Oncology</topic><topic>Humans</topic><topic>Hyperthermia, Induced</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Oncology</topic><topic>Peritoneal Neoplasms - classification</topic><topic>Peritoneal Neoplasms - secondary</topic><topic>Peritoneal Neoplasms - therapy</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Milovanov, Vladimir</creatorcontrib><creatorcontrib>Sardi, Armando</creatorcontrib><creatorcontrib>Studeman, Kimberley</creatorcontrib><creatorcontrib>Nieroda, Carol</creatorcontrib><creatorcontrib>Sittig, Michelle</creatorcontrib><creatorcontrib>Gushchin, Vadim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Milovanov, Vladimir</au><au>Sardi, Armando</au><au>Studeman, Kimberley</au><au>Nieroda, Carol</au><au>Sittig, Michelle</au><au>Gushchin, Vadim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>23</volume><issue>6</issue><spage>1928</spage><epage>1933</epage><pages>1928-1933</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>ABSTRACT
Purpose
We evaluated the 7th edition of the American Joint Committee on Cancer (AJCC) staging classification in terms of overall survival (OS) in patients with PMP treated with cytoreductive surgery (CRS)/hyperthermic intraperitoneal chemotherapy (HIPEC).
Methods
A total of 208 PMP patients treated with CRS/HIPEC were identified from a prospective database. Patients with peritoneal mucinous carcinomatosis (PMCA) were retrospectively staged at time of diagnosis according to AJCC staging classification. Patients with disseminated peritoneal adenomucinosis (DPAM) were evaluated in a separate group.
Results
Median follow-up was 5.2 years. Of 208 patients, 124 had PMCA and 84 patients had DPAM. According to the AJCC staging classification 47 lymph node (LN) negative patients with well-differentiated PMCA, were classified as a stage IVA. 77 patients with either moderately or poorly differentiated PMCA irrespective of LN status, or well-differentiated PMCA with positive LN were classified as stage IVB. 84 patients with DPAM, constituted a separate group. OS of stage IVA and IVB patients was 100, 90, 67, and 91, 50, and 27 for 1, 3, and 5 years, respectively (
p
< 0.001). OS of DPAM patients was 96, 90, and 88 % for 1, 3, and 5 years, respectively (
p
= 0.025 comparing to IVA). PFS was estimated for IVA and IVB PMCA patients who were considered disease free after CRS/HIPEC and was 78, 52, and 43 % in the IVA patients and 65 %, 15 %, and 0 in the IVB group at 1, 3, and 5 years, respectively (
p
= 0.004). The adjusted HR for AJCC stages (IVA/IVB) was 3.7 (95 % confidence interval 2.0–6.7) (
p
< 0.001).
Conclusions
The 7th edition of the AJCC staging classification is a simple, reproducible, and valid classification for staging patients with PMCA undergoing CRS/HIPEC.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>26714951</pmid><doi>10.1245/s10434-015-5047-5</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1068-9265 |
| ispartof | Annals of surgical oncology, 2016-06, Vol.23 (6), p.1928-1933 |
| issn | 1068-9265 1534-4681 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1787479054 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Adenocarcinoma, Mucinous - classification Adenocarcinoma, Mucinous - pathology Adenocarcinoma, Mucinous - therapy Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Appendiceal Neoplasms - classification Appendiceal Neoplasms - pathology Appendiceal Neoplasms - therapy Chemotherapy, Cancer, Regional Perfusion Combined Modality Therapy Cytoreduction Surgical Procedures Female Follow-Up Studies Gastrointestinal Oncology Humans Hyperthermia, Induced Male Medicine Medicine & Public Health Middle Aged Oncology Peritoneal Neoplasms - classification Peritoneal Neoplasms - secondary Peritoneal Neoplasms - therapy Prognosis Prospective Studies Retrospective Studies Surgery Surgical Oncology Survival Rate |
| title | The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T02%3A46%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%207th%20Edition%20of%20the%20AJCC%20Staging%20Classification%20Correlates%20with%20Biologic%20Behavior%20of%20Mucinous%20Appendiceal%20Tumor%20with%20Peritoneal%20Metastases%20Treated%20with%20Cytoreductive%20Surgery%20and%20Hyperthermic%20Intraperitoneal%20Chemotherapy%20(CRS/HIPEC)&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Milovanov,%20Vladimir&rft.date=2016-06-01&rft.volume=23&rft.issue=6&rft.spage=1928&rft.epage=1933&rft.pages=1928-1933&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-015-5047-5&rft_dat=%3Cproquest_cross%3E1787479054%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1787035388&rft_id=info:pmid/26714951&rfr_iscdi=true |